Open Access Highly Accessed Research article

Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy

Alberto Lerario, Filippo Cogiamanian, Chiara Marchesi, Marzia Belicchi, Nereo Bresolin, Laura Porretti and Yvan Torrente*

BMC Musculoskeletal Disorders 2010, 11:157  doi:10.1186/1471-2474-11-157

PubMed Commons is an experimental system of commenting on PubMed abstracts, introduced in October 2013. Comments are displayed on the abstract page, but during the initial closed pilot, only registered users can read or post comments. Any researcher who is listed as an author of an article indexed by PubMed is entitled to participate in the pilot. If you would like to participate and need an invitation, please email info@biomedcentral.com, giving the PubMed ID of an article on which you are an author. For more information, see the PubMed Commons FAQ.

query

Paule Morbois   (2010-07-15 16:12)  Personal

I was only questioning the number in the sample of the study you presented here and the result you may have received provide little or no ground to as the validity based on the sample examined (2 patients only).
Do you intend in continuing such study as to increase the number presented and therefore improve the reliability of such results?


truthfully,

Competing interests

None declared

top

Post a comment